Legislation Would Permit Pharmacists to Administer Long-Acting Injectable Psychiatric Medications

On September 24, 2026, Bill A5539 was introduced in the New Jersey State Assembly, which would amend the pharmacy practice law to permit pharmacists to administer a long-acting injectable drug under a prescription from an authorized prescriber to treat or manage symptoms of a psychiatric condition or disorder for up to 24 weeks with a single dose, as long as the pharmacist is appropriately educated and qualified, as determined by the New Jersey State Board of Pharmacy.